Showing results (31-40 of 40) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 40 results.
Cancer Research and Treatment|October 22, 2024
Second-Line Fluoropyrimidine-Based Chemotherapy in Advanced Biliary Tract Cancer: A Meta-analysis Based on Individual Patient-Level Data of Randomized TrialsJaewon Hyung, Minsu Kang, Ilhwan Kim, et al.
Cancers|July 27, 2022
Changes of Immune Cell Fractions in Patients Treated with Immune Checkpoint InhibitorsHye Ryeon Kim, Jung Hun Kang, Sung Hyun Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|December 26, 2025
Outcomes of Nivolumab Plus Ipilimumab After Atezolizumab Plus Bevacizumab in Advanced HCC: An International Multicentre StudyJung Sun Kim, Jeffrey Wong, San-Chi Chen, et al.
JAMA Network Open|October 1, 2025
Gemcitabine and Cisplatin Plus Polymeric Micellar Paclitaxel and Survival in Advanced Biliary Tract Cancer: A Randomized Clinical TrialHyehyun Jeong, Changhoon Yoo, Ilhwan Kim, et al.
Oncoimmunology|May 4, 2018
A PI3K p110α-selective inhibitor enhances the efficacy of anti-HER2/neu antibody therapy against breast cancer in miceJae-Hyeog Choi, Ki Hyang Kim, Kug-Hwan Roh, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|May 26, 2020
Regorafenib in previously treated advanced hepatocellular carcinoma: Impact of prior immunotherapy and adverse eventsChanghoon Yoo, Seonggyu Byeon, Yeonghak Bang, et al.
Therapeutic Advances in Medical Oncology|September 7, 2019
Real-world efficacy and safety of liposomal irinotecan plus fluorouracil/leucovorin in patients with metastatic pancreatic adenocarcinoma: a study by the Korean Cancer Study GroupChanghoon Yoo, Hyeon-Su Im, Kyu-Pyo Kim, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|June 21, 2020
Regorafenib in patients with advanced Child-Pugh B hepatocellular carcinoma: A multicentre retrospective studyHyung-Don Kim, Yeonghak Bang, Myung Ah Lee, et al.
Clinical and Molecular Hepatology|October 28, 2025
Integrative Multi-Omics Profiling Identifies Infiltrative HCC as an Immunotherapy-Resistant Subtype with Distinct Molecular FeaturesWon Suk Lee, Seonjeong Woo, Sung Hwan Lee, et al.
Liver Cancer|April 21, 2025
Real-World Study of Systemic Treatment after First-Line Atezolizumab plus Bevacizumab for Hepatocellular Carcinoma in Asia-Pacific CountriesChoong-Kun Lee, Changhoon Yoo, Jung Yong Hong, et al.
Pageof 4